AIA
IONS icon

Affinity Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Affinity Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-61,907
Closed -$2.5M – 150
2015
Q3 		$2.5M Buy
+61,907
New +$3.2M 0.23% 101

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Affinity Investment Advisors's IONS Position: Q4 2015 in Review

Affinity Investment Advisors sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 61,907 shares — an estimated $2.5M sold.

Affinity Investment Advisors first reported a position in IONS in Q3 2015 and held it in 1 quarter. The position peaked at $2.5M in Q3 2015. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

  • Affinity Investment Advisors reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Affinity Investment Advisors sold 61,907 Ionis Pharmaceuticals shares in Q4 2015, an estimated $2.5M.
  • Affinity Investment Advisors first reported a position in Ionis Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Affinity Investment Advisors's Ionis Pharmaceuticals position peaked at $2.5M in Q3 2015.
  • 334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Affinity Investment Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.